Nestlé sells peanut allergy business after insufficient demand
Treatment whose rollout was delayed by pandemic will now be run by Swiss group Stallergenes Greer
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Allergy | Allergy & Immunology | Pandemics | Peanuts | Pharmaceuticals | Switzerland Health